Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics

ARNA POWR Grades

• Sentiment is the dimension where ARNA ranks best; there it ranks ahead of 27.88% of US stocks.
• ARNA's strongest trending metric is Quality; it's been moving down over the last 169 days.
• ARNA ranks lowest in Stability; there it ranks in the 6th percentile.

ARNA Stock Summary

• Arena Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 5.58% of US listed stocks.
• With a price/sales ratio of 148,828.9, Arena Pharmaceuticals Inc has a higher such ratio than 100% of stocks in our set.
• As for revenue growth, note that ARNA's revenue has grown -98.87% over the past 12 months; that beats the revenue growth of just 0.7% of US companies in our set.
• Stocks that are quantitatively similar to ARNA, based on their financial statements, market capitalization, and price volatility, are SVRA, ADCT, FSR, BLU, and NYMX.
• ARNA's SEC filings can be seen here. And to visit Arena Pharmaceuticals Inc's official web site, go to www.arenapharm.com.

ARNA Valuation Summary

• ARNA's price/sales ratio is 56703.5; this is 499490.31% higher than that of the median Healthcare stock.
• ARNA's price/earnings ratio has moved up 126.3 over the prior 243 months.
• ARNA's price/earnings ratio has moved up 126.3 over the prior 243 months.

Below are key valuation metrics over time for ARNA.

ARNA Growth Metrics

Its year over year cash and equivalents growth rate is now at 127.37%.
• The 2 year cash and equivalents growth rate now stands at -63.11%.
• Its 5 year price growth rate is now at 215.51%.

ARNA's revenue has moved down $17,933,000 over the prior 33 months.

The table below shows ARNA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	0.037	-437.903	-582.985
2021-06-30	0.057	-395.123	-484.111
2021-03-31	0.057	-379.038	-422.944
2020-12-31	0.319	-353.094	-404.734
2020-09-30	3.284	-308.139	-370.884
2020-06-30	4.614	-285.642	-346.311

ARNA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ARNA has a Quality Grade of C, ranking ahead of 63.92% of graded US stocks.
• ARNA's asset turnover comes in at 0 -- ranking 440th of 680 Pharmaceutical Products stocks.
• MRSN, CRBP, and ARWR are the stocks whose asset turnover ratios are most correlated with ARNA.

The table below shows ARNA's key quality metrics over time.